Ads
related to: dark spot under big toe nail fungus killer spray side effects for women
Search results
Results From The WOW.Com Content Network
Price: $9 per applicator/bottle | Active ingredient: Tolnaftate, 1% | Application: Apply twice a day (morning and night) Fungi-Nail takes the prize for best overall toenail fungus treatment ...
A case of fungal infection of the big toe Advanced fungal infection of the big toe. The most common symptom of a fungal nail infection is the nail becoming thickened and discoloured: white, black, yellow or green. As the infection progresses the nail can become brittle, with pieces breaking off or coming away from the toe or finger completely.
Terbinafine is an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete's foot. [1] [2] [3] It is either taken by mouth or applied to the skin as a cream or ointment.
Dark nails are associated with B 12 deficiency. Stains of the nail plate (not the nail bed) are associated with smoking and henna use. Splinter hemorrhages (or haemorrhages) are tiny blood clots that tend to run vertically under the nails. Drug-induced nail changes are caused by drug usage which may result in various abnormalities. [6]: 665–6
For premium support please call: 800-290-4726 more ways to reach us
Tolnaftate [1] sold under the brand name TAGRID among, others is a synthetic thiocarbamate used as an anti-fungal agent that may be sold without medical prescription in most jurisdictions. It is supplied as a cream, powder, spray, liquid, and liquid aerosol . [ 2 ]
For premium support please call: 800-290-4726 more ways to reach us
Tavaborole, sold under the brand name Kerydin, is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed with a complete clearance rate of 6-7% and partial clearance rate of 23-24% in individuals whose “infection border does not reach the cuticle at the base of the large toenail.” [1] Tavaborole was approved by the US FDA in July ...